NeoGenomics
266 hedge funds and large institutions have $1.89B invested in NeoGenomics in 2023 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 76 increasing their positions, 89 reducing their positions, and 31 closing their positions.
347% more call options, than puts
Call options by funds: $6.74M | Put options by funds: $1.51M
39% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 31
4% more funds holding
Funds holding: 256 → 266 (+10)
0.86% more ownership
Funds ownership: 91.13% → 91.99% (+0.86%)
7% less capital invested
Capital invested by funds: $2.02B → $1.89B (-$135M)
15% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 89
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$16M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$7.32M |
| 4 |
GF
Greenhouse Funds
Baltimore,
Maryland
|
+$6.01M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$15.3M |
| 2 |
BlackRock
New York
|
-$8.77M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$5.74M |
| 4 |
KFO
Kopp Family Office
Bloomington,
Minnesota
|
-$4.71M |
| 5 |
ACM
Altium Capital Management
New York
|
-$4.18M |
NEO Hedge Fund Activity: Q2 2023 in Review
266 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2023, worth a combined $1.89B — down 6.7% from $2.02B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new NEO positions and 31 closed out — a net gain of 12 holders — while 76 added to existing stakes and 89 trimmed.
The largest buyer was Fred Alger Management, adding an estimated $16M. The largest seller was Citadel Advisors, cutting an estimated $15.3M.
- 266 institutional investors held NeoGenomics (NEO) as of Q2 2023, up from 256 in Q1 2023.
- Funds reported $1.89B of NeoGenomics stock for Q2 2023, down 6.7% quarter-over-quarter.
- 43 funds opened new NeoGenomics positions in Q2 2023 and 31 closed out, a net change of +12 holders.
- The largest NeoGenomics buyer in Q2 2023 was Fred Alger Management, an estimated $16M added.
- The largest NeoGenomics seller in Q2 2023 was Citadel Advisors, an estimated $15.3M sold.
Based on aggregated 13F filings for Q2 2023.